Annals of Hematology

, Volume 84, Issue 1, pp 13–18 | Cite as

Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue–type of the orbit and ocular adnexa

  • Jae-Lyun Lee
  • Min-Kyoung Kim
  • Kyung Hee Lee
  • Myung Soo Hyun
  • Hwa Sun Chung
  • Dong Suk Kim
  • Sei One Shin
  • Hee Soon Cho
  • Sung Hwa Bae
  • Hun Mo Ryoo
Original Article


Non-Hodgkin’s lymphomas of the orbit and ocular adnexa (OOA), the majority of which are extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue-type (MALT lymphomas), are a rare disorder. The aim of this study was to evaluate the clinical features and treatment outcomes and complications in patients with MALT lymphoma of OOA. Thirty-seven patients with a histologically verified diagnosis of MALT lymphoma of OOA were included in this retrospective, observational case study. There were 22 (59%) men and 15 (41%) women, with a median age of 44 years (range, 21–80 years). The most common presenting complaint was a slowly growing orbital mass. The stages were IAE in 74%, IAEE (bilateral involvement) in 18%, IIIAE in 6%, and IVAE in 3%. None of the patients had an elevated value of LHD or β2-microglobulin. Surgical resection alone was attempted as the sole treatment in two patients, but tumor recurred 19 and 24 months after surgery. Radiotherapy, with a median tumor dose of 3,060 cGy, was administered in 29 patients; all of the patients achieved complete remission, and none of them had severe later complications. Combination chemotherapy alone was employed in three patients with stage IIIAE or IVAE. With a median follow-up duration of 21 months, the 3-year overall survival (OS) rate and event-free survival (EFS) rate were 97% and 86%, respectively. Subgroup analysis of the patients with localized disease, who received radiotherapy as an initial treatment modality, revealed that 3-year OS rate and EFS rate were 100% and 93%, respectively. All disease recurrences were documented histologically as MALT lymphoma. In conclusion complete staging evaluation is needed to select an adequate treatment modality. Radiotherapy alone can produce excellent local control and survival in patients with localized MALT lymphoma of OOA. Systemic chemotherapy should be considered in patients with advanced stages or systemic manifestation.


Drug therapy Lymphoma Mucosa-associated lymphoid tissue Orbital neoplasms Radiotherapy 


  1. 1.
    Bhatia S, Paulino AC, Buatti JM, Mayr NA, Wen BC (2002) Curative radiotherapy for primary orbital lymphoma. Int J Radiat Oncol Biol Phys 54:818–823CrossRefPubMedGoogle Scholar
  2. 2.
    Cho EY, Han JJ, Ree HJ et al (2003) Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone B-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients. Am J Hematol 73:87–96CrossRefPubMedGoogle Scholar
  3. 3.
    Conconi A, Martinelli G, Thieblemont C et al (2003) Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood 102:2741–2745CrossRefPubMedGoogle Scholar
  4. 4.
    Coupland SE, Krause L, Delecluse HJ et al (1998) Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 cases. Ophthalmology 105:1430–1441CrossRefPubMedGoogle Scholar
  5. 5.
    Esik O, Ikeda H, Mukai K, Kaneko A (1996) A retrospective analysis of different modalities for treatment of primary orbital non-Hodgkin’s lymphomas. Radiother Oncol 38:13–18CrossRefPubMedGoogle Scholar
  6. 6.
    Freeman C, Berg JW, Cutler SJ (1972) Occurrence and prognosis of extra-nodal lymphomas. Cancer 29:252–260PubMedGoogle Scholar
  7. 7.
    Fung CY, Tarbell NJ, Lucarelli MJ, Goldberg SI et al (2003) Ocular adnexal lymphoma: clinical behavior or distinct World Health Organization classification subtypes. Int J Radiat Oncol Biol Phys 57:1382–1391CrossRefPubMedGoogle Scholar
  8. 8.
    Galieni P, Polito E, Leccisotti A et al (1997) Localized orbital lymphoma. Haematologica 82:436–439PubMedGoogle Scholar
  9. 9.
    Garner A (1992) Orbital lymphoproliferative disorders. Br J Ophthalmol 76:47–48PubMedGoogle Scholar
  10. 10.
    Harris NL, Jaffe ES, Stein H et al (1994) A revised European–American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84:1361–1392Google Scholar
  11. 11.
    Harris NL, Jaffe ES, Diebold J et al (1999) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting—Airlie House, Virginia, November 1997. J Clin Oncol 17:3835–3849PubMedGoogle Scholar
  12. 12.
    Hasegawa M, Kojima M, Shioya M et al (2003) Treatment results of radiotherapy for malignant lymphoma of the orbit and histopathologic review according to the WHO classification. Int J Radiat Oncol Biol Phys 57:172–176CrossRefPubMedGoogle Scholar
  13. 13.
    Isaacson PG, Wright DH (1983) Malignant lymphoma of mucosa-associated lymphoid tissue: a distinctive of B-cell lymphoma. Cancer 52:1410–1416PubMedGoogle Scholar
  14. 14.
    Isaacson PG, Norton AJ (1994) Mucosa associated lymphoid tissue (MALT) and the MALT lymphoma concept: extranodal lymphomas. Churchill Livingstone, Edinburgh, pp 5–14Google Scholar
  15. 15.
    Jenkins C, Rose GE, Bunce C et al (2000) Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survival. Br J Ophthalmol 84:907–913CrossRefPubMedGoogle Scholar
  16. 16.
    Keleit D, Flickinger JC, Hobson SR et al (1992) Radiotherapy of lymphoproliferative disease of the orbit. Am J Clin Oncol 15:422–427PubMedGoogle Scholar
  17. 17.
    Ko YH, Kim CW, Park CS et al (1998) REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma. Cancer 83:806–812 (Erratum 1999;85:256)CrossRefPubMedGoogle Scholar
  18. 18.
    Lee SW, Suh CO, Kim GE et al (2002) Role of radiotherapy for primary orbital lymphoma. Am J Clin Oncol 25:261–265CrossRefPubMedGoogle Scholar
  19. 19.
    Pelloski CE, Wilder RB, Ha CS et al (2001) Clinical Stage IEA-IIEA orbital lymphomas: outcomes in the era of modern staging and treatment. Radiother Oncol 59:145–151CrossRefPubMedGoogle Scholar
  20. 20.
    Raderer M, Vorbeck F, Formanek M et al (2000) Importance of extensive staging in patients with mucosa-associated lymphoid tissue (MALT)-type lymphoma. Br J Cancer 83:454–457CrossRefPubMedGoogle Scholar
  21. 21.
    Sasai K, Yamabe H, Dodo Y, Kashii S, Nagata Y, Hiraoka M (2001) Non-Hodgkin’s lymphoma of the ocular adnexa. Acta Oncol 40:485–490CrossRefPubMedGoogle Scholar
  22. 22.
    Smitt MC, Donaldson SS (1993) Radiotherapy is successful treatment for orbital lymphoma. Int J Radiat Oncol Biol Phys 26:59–66PubMedGoogle Scholar
  23. 23.
    Thieblemont C, Bastion Y, Berger F et al (1997) Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients. J Clin Oncol 15:1624–1630PubMedGoogle Scholar
  24. 24.
    Tsang RW, Gospodarowicz MK, Pintilie M et al (2001) Stage I and II MALT lymphoma: results of treatment with radiotherapy. Int J Radiat Oncol Biol Phys 50:1258–1264CrossRefPubMedGoogle Scholar
  25. 25.
    Uno T, Isobe K, Shikama N et al (2003) Radiotherapy for extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional retrospective review of 50 patients. Cancer 98:865–871CrossRefPubMedGoogle Scholar
  26. 26.
    Wenzel C, Fiebiger W, Dieckmann K, Formanek M, Chott A, Raderer M (2003) Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of the head and neck area: high rate of disease recurrence following local therapy. Cancer 97:2236–2241CrossRefPubMedGoogle Scholar
  27. 27.
    Wotherspoon A, Doglioni C, Isaacson PG (1992) Low-grade gastric B-cell lymphoma of mucosa associated lymphoid tissue (MALT): a multifocal disease. Histopathology 20:29–34PubMedGoogle Scholar
  28. 28.
    Yahalom J (2001) MALT lymphomas: a radiation oncology viewpoint. Ann Hematol 80[Suppl 3]:B100–B105PubMedGoogle Scholar
  29. 29.
    Zinzani PL, Magagnoli M, Galieni P et al (1999) Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients. J Clin Oncol 17:1254–1258PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • Jae-Lyun Lee
    • 1
  • Min-Kyoung Kim
    • 1
  • Kyung Hee Lee
    • 1
  • Myung Soo Hyun
    • 1
  • Hwa Sun Chung
    • 2
  • Dong Suk Kim
    • 3
  • Sei One Shin
    • 4
  • Hee Soon Cho
    • 5
  • Sung Hwa Bae
    • 6
  • Hun Mo Ryoo
    • 6
  1. 1.Department of MedicineYeungnam University College of MedicineDaeguSouth Korea
  2. 2.Department of OphthalmologyYeungnam University College of MedicineDaeguSouth Korea
  3. 3.Department of PathologyYeungnam University College of MedicineDaeguSouth Korea
  4. 4.Department of Radiation OncologyYeungnam University College of MedicineDaeguSouth Korea
  5. 5.Department of Laboratory MedicineYeungnam University College of MedicineDaeguSouth Korea
  6. 6.Department of MedicineCatholic University of DaeguDaeguSouth Korea

Personalised recommendations